| [1] |
Cheng YC, Chou YH, Chiou HJ, et al. Liposarcoma of the spermatic cord: a report of two cases and a review of the literature[J]. J Med Ultrasound, 2004, 12(4): 125-130.
|
| [2] |
Demirci U, Buyukberber S, Cakir A, et al. Synchronous testicular liposarcoma and prostate adenocarcinoma: a case report[J]. Cases J, 2010, 3(1): 27.
|
| [3] |
Chintamani , Tandon M, Khandelwal R, et al. Liposarcoma of the spermatic cord: a diagnostic dilemma[J]. JRSM Short Rep, 2010, 1(6): 49.
|
| [4] |
Gregorio MD, D'Hondt L, Lorge F, et al. Liposarcoma of the spermatic cord: an infrequent pathology[J]. Case Rep Oncol, 2017, 10(1): 136-142.
|
| [5] |
Fagundes MA, Zietman AL, Althausen AF, et al. The management of spermatic cord sarcoma[J]. Cancer, 1996, 77(9): 1873-1876.
|
| [6] |
Kryvenko ON, Rosenberg AE, Merce J, et al. Dedifferentiated liposarcoma of the spermatic cord: a series of 42 cases[J]. Am J Surg Pathol, 2015, 39(9): 1219-1225.
|
| [7] |
Ushida H, Johnin K, Koizumi S, et al. Liposarcoma of the spermatic cord in the left scrotum and inguinal region: a case report[J]. Hinyokika Kiyo, 2000, 46(5): 349-351.
|
| [8] |
Malizia M, Brunocilla E, Bertaccini A, et al. Liposarcoma of the spermatic cord: description of two cases and review of the literature[J]. Arch Ital Urol Androl, 2005, 77(2): 115-117.
|
| [9] |
Kyratzi I, Lolis E, Antypa E, et al. Imaging features of a huge spermatic cord leiomyosarcoma: review of the literature[J]. World J Radiol, 2011, 3(4): 114-119.
|
| [10] |
Yamamichi G, Nakata W, Yamamoto A, et al. Liposarcoma of the spermatic cord associated with scrotum lipoma: A case report and review of the literature[J]. Urol Case Rep, 2018, 17(C): 114-116.
|
| [11] |
S Aslam S, Dow-Mu K, Husband JE. The role of imaging in the diagnosis, staging, and management of testicular cancer[J]. AJR Am J Roentgenol, 2008, 191(2): 387-395.
|
| [12] |
Dogra VS, Gottlieb RH, Oka M, et al. Sonography of the scrotum.[J]. Invest Radiol, 1983, 18(2): 112-121.
|
| [13] |
Benson CB, Doubilet PM, Richie JP. Sonography of the male genital tract[J]. AJR Am J Roentgenol, 1989, 153(4): 705-713.
|
| [14] |
Voyvoda N, Voyvoda B, Çamurdan O. The role of imaging in testicular cancer diagnosis, staging and follow-up[J]. Ueroonkoloji Buelteni, 2017, 16(2): 51-56.
|
| [15] |
Flohr TG, Schaller S, Stierstorfer K, et al. Multi-detector row CT systems and image-reconstruction techniques[J]. Radiol, 2005, 235(3): 756-773.
|
| [16] |
Thurnher S, Hricak H, Carroll PR, et al. Imaging the testis: comparison between MR imaging and US[J]. Radiology, 1988, 167(3): 631-636.
|
| [17] |
Schultz-Lampel D, Bogaert G, Thüroff JW, et al. MRI for evaluation of scrotal pathology[J]. Urol Res, 1991, 19(5): 289-292.
|
| [18] |
Johnson JO, Mattrey RF, Phillipson J. Differentiation of seminomatous from nonseminomatous testicular tumors with MR imaging[J]. AJR Am J Roentgenol, 1990, 154(3): 539-543.
|
| [19] |
Tsili AC, Constantine T, Xenofon G, et al. MRI in the histologic characterization of testicular neoplasms[J]. AJR Am J Roentgenol, 2007, 189(6): 331-337.
|
| [20] |
Pilotti S, Torre G, Della , Mezzelani A, et al. The expression of MDM2/CDK4 gene product in the differential diagnosis of well differentiated liposarcoma and large deep-seated lipoma[J]. Br J Cancer, 2000, 82(7): 1271-1275.
|
| [21] |
Saâda-Bouzid E, Burel-Vandenbos F, Ranchère-Vince D, et al. Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas[J]. Mod Pathol, 2015, 28(11): 1404-1414.
|
| [22] |
Ware PL, Snow AN, Maya G, et al. MDM2 copy numbers in well-differentiated and dedifferentiated liposarcoma: characterizing progression to high-grade tumors[J]. Am J Clin Pathol, 2014, 141(3): 334-341.
|
| [23] |
Crago AM, Socci ND, Penelope DC, et al. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability[J]. Clin Cancer Res, 2012, 18(5): 1334-1340.
|
| [24] |
Coindre JM, Mariani O, Chibon F, et al. Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma[J]. Mod Pathol, 2003, 16(3): 256-262.
|
| [25] |
Antoine I, Laurence B, Elisabet G, et al. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas[J]. Clin Cancer Res, 2009, 15(18): 5696-5703.
|
| [26] |
Seung Eun L, Jin KY, Jeong KM, et al. High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma[J]. Histol Histopathol, 2013, 29(1): 127-138.
|
| [27] |
Pilotti S, Torre G, Della , Lavarino C, et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms[J]. J Pathol, 2015, 181(1): 14-24.
|
| [28] |
Mariani O, Brennetot C, Coindre JM, et al. Oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas[J]. Cancer Cell, 2007, 11(4): 361-374.
|
| [29] |
Snyder EL, Sandstrom DJ, Kenneth L, et al. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme[J]. J Pathol, 2010, 218(3): 292-300.
|
| [30] |
Volm M, Koomägi R. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival[J]. Br J Cancer, 2000, 82(10): 1747-1754.
|
| [31] |
Dong Y, Sui L, Sugimoto K, et al. Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas[J]. Int J Cancer, 2015, 95(4): 209-215.
|
| [32] |
Ronald S, Kirsten S, Peter S, et al. Amplification pattern of 12q13-q15 genes(MDM2, CDK4, GLI) in urinary bladder cancer[J]. Oncogene, 2002, 21(16): 2476-2483.
|
| [33] |
Zhao P, Hu YC, Talbot IC. Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma[J]. World J Gastroenterol, 2003, 9(10): 2202-2206.
|
| [34] |
Ghazizadeh M, Jin E, Shimizu H, et al. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas[J]. Respiration, 2005, 72(1): 68-73.
|
| [35] |
Castro IPD, Cárcer GD, Montoya G, et al. Emerging cancer therapeutic opportunities by inhibiting mitotic kinases[J]. Curr Opin Pharmacol, 2008, 8(4): 375-383.
|
| [36] |
Cormio G, Loizzi V, Carriero C, et al. Conservative management of uterine leiomyosarcoma: report of a failure[J]. Eur J Gynaecol Oncol, 2009, 30(2): 206-207.
|
| [37] |
Bozzini G, Albersen M, Romero OJ, et al. Feasibility and safety of conservative surgery for the treatment of spermatic cord leiomyosarcoma[J]. Int J Surg, 2015, 24(Pt A): 81-84.
|
| [38] |
Kinjo M, Hokamura K, Tanaka K, et al. Leiomyosarcoma of the spermatic cord. a case report and a brief review of literature[J]. Acta Pathol Jpn, 2010, 36(6): 929-934.
|
| [39] |
谢乾坤，叶军锋，柴文刚, 等. 增生性精索炎伴坏死误诊为腹股沟斜疝嵌顿一例[J/OL]. 中华疝和腹壁外科杂志(电子版), 2018, 12(1): 68-69.
|
| [40] |
Coleman J, Brennan MF, Alektiar K, et al. Adult spermatic cord sarcomas: management and results[J]. Ann Surg Oncol, 2003, 10(6): 669-675.
|
| [41] |
Soipi S, Vucic M, Ulamec M, et al. Leiomyosarcoma of the spermatic cord with scalp metastasis: case report and literature review[J]. Coll Antropol, 2014, 38(2): 763-766.
|